Plus   Neg

Arthur J. Gallagher Q4 Profit Up

Arthur J. Gallagher & Co. (AJG) Thursday reported fourth-quarter net earnings of $118.7 million or $0.63 per share, up from $84.3 million or $0.44 per share last year.

Adjusted earnings for the quarter were $0.67 per share, up from $0.53 per share last year.

Revenues for the quarter were $1.19 billion, up from $1.00 billion last year.

Analysts polled by Thomson Reuters estimated earnings of $0.52 per share and revenues of $1.40 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients. The U.S. federal government's General Services Administration or GSA has awarded a five-year federal transportation contract, estimated to be worth up to $810 million, to Uber Technologies Inc. and Lyft Inc., according to multiple reports. Under the contract, the ride-hailing companies would provide services to various public agencies and their around 4 million employees across the nation.
Follow RTT